3 completed, 3 terminated, 2 not yet recruiting, 2 recruiting. 4 Phase 2, 2 Not applicable, 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 3, Completed 1 |
| Not applicable | 2 | Recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Renal Neoplasms: new trials by email Literature Review of Renal Neoplasms trials Research Report on Renal Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Non-Clamping and Sutureless Technique on Postoperative Renal Function in Robot-Assisted Partial Nephrectomy Off-Clamp, Sutureless Robot-Assisted Partial Nephrectomy, Conventional Robot-Assisted Partial Nephrectomy With Artery Clamping and Sutured Reconstruction - Renal Neoplasms, Localized Kidney Tumors | Not applicable | Recruiting | Shao Pengfei | 304 | 2026-10-01 | 2026-10-22 |
| AI for Renal Tumors Using Non-Contrast CT Renal Neoplasms, Renal Cyst | Not yet recruiting | Fudan University | 10000 | 2026-01-01 | 2025-12-26 | |
| Tumor Rupture During Robotic Partial Nephrectomy robot-assisted partial nephrectomy - Kidney Cancer, Renal Neoplasms | Not yet recruiting | Azienda Ospedaliera Universitaria Integrata Verona | 100 | 2025-09-01 | 2025-07-15 | |
| Optimising Renal Tumour Management Through Artificial Intelligence Modules Renal Neoplasms, Pathology | Recruiting | Shao Pengfei | 2100 | 2025-01-01 | 2025-03-19 | |
| Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) NKT2152, palbociclib, sasanlimab - ccRCC, Clear Cell Renal Cell Carcinoma | Phase 2 | Terminated | NiKang Therapeutics, Inc. | 18 | 2023-07-28 | 2025-11-12 |
| A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma Oral NKT2152 - ccRCC, Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | Terminated | NiKang Therapeutics, Inc. | 120 | 2021-10-26 | 2025-11-12 |
| Study of Nivolumab for Advanced Cancers in India Nivolumab - Non-Small Cell Lung Cancer (NSCLC), Non-Small-Cell Lung Carcinoma | Phase 4 | Completed | Bristol-Myers Squibb | 100 | 2018-03-06 | 2020-12-04 |
| A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer SGI-110 (guadecitabine) - Paraganglioma, Gastrointestinal Stromal Tumors | Phase 2 | Terminated | National Cancer Institute (NCI) | 9 | 2017-08-16 | 2026-02-18 |
| A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment sunitinib - Renal Neoplasms, Targeted Molecular Therapy | Not applicable | Unknown | First Affiliated Hospital, Sun Yat-Sen University | 300 | 2016-07-01 | 2016-02-25 |
| Extracolonic Findings on Computed Tomography (CT) Colonography Solitary Pulmonary Nodules, Multiple Pulmonary Nodules | Unknown | American College of Radiology Imaging Network | 520 | 2011-09-01 | 2018-10-11 | |
| Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. 124-Iodine-cG250 (124I-cG250) - Cancer of Kidney, Kidney Cancer | Phase 1 | Completed | Ludwig Institute for Cancer Research | 26 | 2005-06-01 | 2022-10-10 |
| Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer docetaxel, tariquidar, 99mTc-sestamibi imaging - Lung Neoplasms, Ovarian Neoplasms | Phase 2 | Completed | National Cancer Institute (NCI) | 48 | 2003-09-01 | 2012-10-12 |
Kidney Neoplasms (12) · Carcinoma, Renal Cell (5) · Adenocarcinoma (1) · Adrenal Gland Neoplasms (1) · Aortic Aneurysm, Abdominal (1) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Gastrointestinal Stromal Tumors (1) · Hypoxia (1) · Kidney Diseases (1) · Liver Neoplasms (1) · Lung Neoplasms (1) · Lymphadenopathy (1) · Multiple Pulmonary Nodules (1) · Neoplasms (1)
Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Male Urogenital Diseases (12) · Urogenital Diseases (12) · Kidney Diseases (11) · Neoplasms (11) · Neoplasms by Site (11) · Urogenital Neoplasms (11) · Urologic Diseases (11) · Urologic Neoplasms (11) · Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (5) · Adenocarcinoma (4) · Carcinoma (4) · Lung Diseases (3)
Docetaxel (1) · Nivolumab (1) · Sunitinib (1) · Technetium Tc 99m Sestamibi (1) · guadecitabine (1) · palbociclib (1) · tariquidar (1)
National Cancer Institute (NCI) (2) · NiKang Therapeutics, Inc. (2) · Shao Pengfei (2) · American College of Radiology Imaging Network (1) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Bristol-Myers Squibb (1) · First Affiliated Hospital, Sun Yat-Sen University (1) · Fudan University (1) · Ludwig Institute for Cancer Research (1)
United States (5) · China (3) · India (1) · Italy (1)
Chaitanya R Divgi, MD (1) · Hanna M. Zafar, MD, MHS (1) · John W Glod, M.D. (1) · Jun-Hang Luo, MD (1) · Pengfei Shao (1) · Pual Russo, MD (1) · Susan E Bates, M.D. (1)